Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients

…, A Lleó, C Casasnovas, C Homedes… - Journal of Neurology …, 2021 - jnnp.bmj.com
Objective To study baseline serum neurofilament light chain (sNfL) levels as a prognostic
biomarker in Guillain-Barré syndrome (GBS). Methods We measured NfL in serum (98 samples…

[HTML][HTML] Autoantibody screening in Guillain–Barré syndrome

…, J Turón, C Casasnovas, C Homedes… - Journal of …, 2021 - Springer
Background Guillain–Barré syndrome (GBS) is an acute inflammatory neuropathy with a
heterogeneous presentation. Although some evidences support the role of autoantibodies in its …

[HTML][HTML] Hoehn and Yahr stage and striatal Dat-SPECT uptake are predictors of Parkinson's disease motor progression

…, G Hoeglinger, C Homedes… - Frontiers in …, 2021 - frontiersin.org
Currently, no treatments available for Parkinson’s disease (PD) can slow PD progression. At
the early stage of the disease, only a subset of individuals with PD progress quickly, while …

[HTML][HTML] Quality of life in myasthenia gravis and correlation of MG-QOL15 with other functional scales

L Diez Porras, C Homedes, MA Alberti… - Journal of Clinical …, 2022 - mdpi.com
Health-related quality of life (HRQOL) in myasthenia gravis (MG) is frequently decreased.
Further, there are many validated clinical scales and questionnaires to evaluate the clinical …

[HTML][HTML] Observational study of patients in Spain with amyotrophic lateral sclerosis: correlations between clinical status, quality of life, and dignity

Y Martínez-Campo, C Homedes, A Lazaro, R Alarcón… - BMC palliative …, 2017 - Springer
Background Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease
that dramatically affects patients’ quality of life (QoL) and dignity of life (DoL). We aimed to …

[HTML][HTML] Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis

L Díez-Porras, C Homedes, MA Alberti… - Scientific reports, 2020 - nature.com
Corticosteroids may produce a paradoxical worsening of myasthenia gravis (MG) symptoms
within the first weeks of treatment. We therefore wanted to assess the hypothesis that a prior …

Eculizumab as a promising treatment in thymoma-associated myasthenia gravis

…, V Nedkova, L Díez, C Homedes… - Therapeutic …, 2020 - journals.sagepub.com
Myasthenia gravis is a chronic autoimmune disorder caused by antibodies directed against
the neuromuscular junction. Some patients may have an associated thymoma, which confers …

A novel mutation in the GFAP gene expands the phenotype of Alexander disease

…, A Schlüter, A Pons-Escoda, C Homedes… - Journal of Medical …, 2019 - jmg.bmj.com
Background Alexander disease, an autosomal dominant leukodystrophy, is caused by
missense mutations in GFAP. Although mostly diagnosed in children, associated with severe …

[HTML][HTML] ClinPrior: an algorithm for diagnosis and novel gene discovery by network-based prioritization

…, C Guilera, JJ Martínez, C Homedes-Pedret… - Genome medicine, 2023 - Springer
Background Whole-exome sequencing (WES) and whole-genome sequencing (WGS) have
become indispensable tools to solve rare Mendelian genetic conditions. Nevertheless, there …

Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in internal medicine and neurology. The ALADIN study

…, S Montull, H Quesada, X Ustrell, C Homedes… - Revista Clínica …, 2018 - Elsevier
Objective To identify factors associated with poor anticoagulation control with vitamin K
antagonists (VKA) among outpatients with nonvalvular atrial fibrillation (NVAF) attended in …